Your browser doesn't support javascript.
loading
Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes.
Cogle, Christopher R; Collins, Bradley; Turner, Daniel; Pettiford, Leslie C; Bossé, Raphael; Hawkins, Kimberly E; Beachamp, Zackary; Wise, Elizabeth; Cline, Christina; May, William S; Moreb, Jan S; Hsu, Jack; Hiemenz, John; Brown, Randall; Norkin, Maxim; Wingard, John R; Uckun, Fatih.
Afiliação
  • Cogle CR; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Collins B; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Turner D; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Pettiford LC; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Bossé R; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Hawkins KE; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Beachamp Z; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Wise E; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Cline C; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • May WS; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Moreb JS; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Hsu J; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Hiemenz J; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Brown R; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Norkin M; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Wingard JR; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Uckun F; Oncotelic Inc, Agoura Hills, CA, USA.
Br J Haematol ; 189(5): e211-e213, 2020 06.
Article em En | MEDLINE | ID: mdl-32236943
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilbenos / Síndromes Mielodisplásicas / Pró-Fármacos / Leucemia Mieloide Aguda / Terapia de Salvação / Difosfatos / Antineoplásicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilbenos / Síndromes Mielodisplásicas / Pró-Fármacos / Leucemia Mieloide Aguda / Terapia de Salvação / Difosfatos / Antineoplásicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article